CVE-2025-64642
Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
7.1
Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
- Record
CVE-2025-64642- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N - CVSS 3.1
- 8.0 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H - Weakness
- CWE-732
- Updated
- 2026-11-02
EUVDEUVD-2025-200324
7.1
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
- Record
EUVD-2025-200324- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-884g-x96w-frc5
7.1
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure...
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
- Record
GHSA-884g-x96w-frc5- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 8.0 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H - Weakness
- CWE-732
- Updated
- 2026-11-02
NVD
7.1
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
- Record
CVE-2025-64642- CVSS 4.0
- 7.1 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 8.0 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H - CVSS 3.1
- 7.8 High
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-732
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-64642 is a high vulnerability (CVSS 7.1) in Mirion Medical Ec2 Software Nmis Biodose, published December 2, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.12%, the 2nd percentile. No source names a fixed version.